
New technologies and adaptations of existing technologies can improve platform processes.
Paul Mensah, PhD, is an associate research fellow, at Pfizer Global Research and Development Global Biologics, Bioprocess R&D

New technologies and adaptations of existing technologies can improve platform processes.

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.

March 2nd 2010